149 related articles for article (PubMed ID: 12322788)
1. Treatment with taurine, diltiazem, and vitamin E retards the progressive visual field reduction in retinitis pigmentosa: a 3-year follow-up study.
Pasantes-Morales H; Quiroz H; Quesada O
Metab Brain Dis; 2002 Sep; 17(3):183-97. PubMed ID: 12322788
[TBL] [Abstract][Full Text] [Related]
2. Effect of nilvadipine on central visual field in retinitis pigmentosa: a 30-month clinical trial.
Nakazawa M; Ohguro H; Takeuchi K; Miyagawa Y; Ito T; Metoki T
Ophthalmologica; 2011; 225(2):120-6. PubMed ID: 20948238
[TBL] [Abstract][Full Text] [Related]
3. Further evaluation of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment: subgroup analyses.
Berson EL; Rosner B; Sandberg MA; Weigel-DiFranco C; Moser A; Brockhurst RJ; Hayes KC; Johnson CA; Anderson EJ; Gaudio AR; Willett WC; Schaefer EJ
Arch Ophthalmol; 2004 Sep; 122(9):1306-14. PubMed ID: 15364709
[TBL] [Abstract][Full Text] [Related]
4. A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa.
Berson EL; Rosner B; Sandberg MA; Hayes KC; Nicholson BW; Weigel-DiFranco C; Willett W
Arch Ophthalmol; 1993 Jun; 111(6):761-72. PubMed ID: 8512476
[TBL] [Abstract][Full Text] [Related]
5. Clinical trial of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment.
Berson EL; Rosner B; Sandberg MA; Weigel-DiFranco C; Moser A; Brockhurst RJ; Hayes KC; Johnson CA; Anderson EJ; Gaudio AR; Willett WC; Schaefer EJ
Arch Ophthalmol; 2004 Sep; 122(9):1297-305. PubMed ID: 15364708
[TBL] [Abstract][Full Text] [Related]
6. Calcium channel blocker D-cis-diltiazem does not slow retinal degeneration in the PDE6B mutant rcd1 canine model of retinitis pigmentosa.
Pearce-Kelling SE; Aleman TS; Nickle A; Laties AM; Aguirre GD; Jacobson SG; Acland GM
Mol Vis; 2001 Feb; 7():42-7. PubMed ID: 11239245
[TBL] [Abstract][Full Text] [Related]
7. Chlorogenic acid supplementation improves multifocal electroretinography in patients with retinitis pigmentosa.
Shin JY; Yu HG
J Korean Med Sci; 2014 Jan; 29(1):117-21. PubMed ID: 24431915
[TBL] [Abstract][Full Text] [Related]
8. Clinical trial of lutein in patients with retinitis pigmentosa receiving vitamin A.
Berson EL; Rosner B; Sandberg MA; Weigel-DiFranco C; Brockhurst RJ; Hayes KC; Johnson EJ; Anderson EJ; Johnson CA; Gaudio AR; Willett WC; Schaefer EJ
Arch Ophthalmol; 2010 Apr; 128(4):403-11. PubMed ID: 20385935
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up of retinitis pigmentosa patients with multifocal electroretinography.
Nagy D; Schönfisch B; Zrenner E; Jägle H
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4664-71. PubMed ID: 18566474
[TBL] [Abstract][Full Text] [Related]
10. Retinitis pigmentosa: rod photoreceptor rescue by a calcium-channel blocker in the rd mouse.
Frasson M; Sahel JA; Fabre M; Simonutti M; Dreyfus H; Picaud S
Nat Med; 1999 Oct; 5(10):1183-7. PubMed ID: 10502823
[TBL] [Abstract][Full Text] [Related]
11. Disease course of patients with X-linked retinitis pigmentosa due to RPGR gene mutations.
Sandberg MA; Rosner B; Weigel-DiFranco C; Dryja TP; Berson EL
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1298-304. PubMed ID: 17325176
[TBL] [Abstract][Full Text] [Related]
12. Long-term effects of nilvadipine against progression of the central visual field defect in retinitis pigmentosa: an extended study.
Nakazawa M; Suzuki Y; Ito T; Metoki T; Kudo T; Ohguro H
Biomed Res Int; 2013; 2013():585729. PubMed ID: 24319686
[TBL] [Abstract][Full Text] [Related]
13. Absence of photoreceptor rescue with D-cis-diltiazem in the rd mouse.
Pawlyk BS; Li T; Scimeca MS; Sandberg MA; Berson EL
Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1912-5. PubMed ID: 12036998
[TBL] [Abstract][Full Text] [Related]
14. Ganglioside administration in retinitis pigmentosa.
Newsome DA; Dorsey FC; May JG; Bergsma DR; Bazan NG
J Ocul Pharmacol; 1987; 3(4):323-32. PubMed ID: 3332681
[TBL] [Abstract][Full Text] [Related]
15. Concentric retinitis pigmentosa: clinicopathologic correlations.
Milam AH; De Castro EB; Smith JE; Tang WX; John SK; Gorin MB; Stone EM; Aguirre GD; Jacobson SG
Exp Eye Res; 2001 Oct; 73(4):493-508. PubMed ID: 11825021
[TBL] [Abstract][Full Text] [Related]
16. Effect of Oral Valproic Acid vs Placebo for Vision Loss in Patients With Autosomal Dominant Retinitis Pigmentosa: A Randomized Phase 2 Multicenter Placebo-Controlled Clinical Trial.
Birch DG; Bernstein PS; Iannacone A; Pennesi ME; Lam BL; Heckenlively J; Csaky K; Hartnett ME; Winthrop KL; Jayasundera T; Hughbanks-Wheaton DK; Warner J; Yang P; Fish GE; Teske MP; Sklaver NL; Erker L; Chegarnov E; Smith T; Wahle A; VanVeldhuisen PC; McCormack J; Lindblad R; Bramer S; Rose S; Zilliox P; Francis PJ; Weleber RG
JAMA Ophthalmol; 2018 Aug; 136(8):849-856. PubMed ID: 29879277
[TBL] [Abstract][Full Text] [Related]
17. Association of Vitamin A Supplementation With Disease Course in Children With Retinitis Pigmentosa.
Berson EL; Weigel-DiFranco C; Rosner B; Gaudio AR; Sandberg MA
JAMA Ophthalmol; 2018 May; 136(5):490-495. PubMed ID: 29596553
[TBL] [Abstract][Full Text] [Related]
18. Effects of subtenon-injected autologous platelet-rich plasma on visual functions in eyes with retinitis pigmentosa: preliminary clinical results.
Arslan U; Özmert E; Demirel S; Örnek F; Şermet F
Graefes Arch Clin Exp Ophthalmol; 2018 May; 256(5):893-908. PubMed ID: 29546474
[TBL] [Abstract][Full Text] [Related]
19. Slowing the degenerative process, long lasting effect of hyperbaric oxygen therapy in retinitis pigmentosa.
Vingolo EM; Rocco M; Grenga P; Salvatore S; Pelaia P
Graefes Arch Clin Exp Ophthalmol; 2008 Jan; 246(1):93-8. PubMed ID: 17674017
[TBL] [Abstract][Full Text] [Related]
20. Progression of defects in the central 10-degree visual field of patients with retinitis pigmentosa and choroideremia.
Hirakawa H; Iijima H; Gohdo T; Imai M; Tsukahara S
Am J Ophthalmol; 1999 Apr; 127(4):436-42. PubMed ID: 10218696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
